terazosin

Generic: terazosin

Labeler: northwind health company, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name terazosin
Generic Name terazosin
Labeler northwind health company, llc
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

terazosin hydrochloride 2 mg/1

Manufacturer
Northwind Health Company, LLC

Identifiers & Regulatory

Product NDC 51655-915
Product ID 51655-915_49741c96-db68-402a-e063-6394a90a07e4
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA075614
Listing Expiration 2027-12-31
Marketing Start 2023-06-26

Pharmacologic Class

Classes
adrenergic alpha-antagonists [moa] alpha-adrenergic blocker [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 51655915
Hyphenated Format 51655-915

Supplemental Identifiers

RxCUI
313217
UNII
D32S14F082

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name terazosin (source: ndc)
Generic Name terazosin (source: ndc)
Application Number ANDA075614 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 2 mg/1
source: ndc
Packaging
  • 30 CAPSULE in 1 BOTTLE, PLASTIC (51655-915-52)
source: ndc

Packages (1)

51655-915-52 30 CAPSULE in 1 BOTTLE, PLASTIC (51655-915-52)

Ingredients (1)

terazosin hydrochloride (2 mg/1)

Linked Drug Pages (1)

terazosin ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "49741c96-db68-402a-e063-6394a90a07e4", "openfda": {"unii": ["D32S14F082"], "rxcui": ["313217"], "spl_set_id": ["ff0efbc2-d7aa-9783-e053-6394a90a384f"], "manufacturer_name": ["Northwind Health Company, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE, PLASTIC (51655-915-52)", "package_ndc": "51655-915-52", "marketing_start_date": "20230626"}], "brand_name": "terazosin", "product_id": "51655-915_49741c96-db68-402a-e063-6394a90a07e4", "dosage_form": "CAPSULE", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "51655-915", "generic_name": "terazosin", "labeler_name": "Northwind Health Company, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "terazosin", "active_ingredients": [{"name": "TERAZOSIN HYDROCHLORIDE", "strength": "2 mg/1"}], "application_number": "ANDA075614", "marketing_category": "ANDA", "marketing_start_date": "20230626", "listing_expiration_date": "20271231"}